NCT06318858 Daily and Weekly Iron Supplementation in Infants
| NCT ID | NCT06318858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Anemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-03-15 |
| Primary Completion | 2024-08-14 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study aims to compare the efficacy of daily iron supplementation and weekly iron supplementation in infants aged 6-12 months on the prevalence of anemia, hemoglobin level, and serum ferritin levels. Infants will be enrolled at 6 months and will be randomly assigned to receive either daily or weekly iron supplementation for the first 3 months and will be followed by weekly iron supplementation for another 3 months.
Eligibility Criteria
Inclusion Criteria: * Apparently healthy infant, aged 6 months ± 2 weeks * Having a birth weight between 2,500 and 4,000 grams * Being born full term (37 to 41 weeks of age + 6 days) * Having hemoglobin ≥ 10.5 g/dL * Being planned to breastfeed with complementary food and/or complementary foods with formula milk Exclusion Criteria: * Infants with chronic illnesses or thalassemia clinical signs such as anemia, enlarged liver, or spleen (if parental history suggests the child is at risk of developing a thalassemia disease that may not show clinical symptoms) * Previously or currently taking an iron supplement